drugset / Trial / NCT04324346
Central Catheters Used for Chemotherapy in Women With Breast Cancer
Completed
250 enrolled
Swedish Red Cross University College
KTH Royal Institute of Technology · collabKarolinska Institutet · collabKarolinska University Hospital · collabNorwegian University of Science and Technology · collabStockholm South General Hospital · collab
RandomizedParallel-groupOpen-labelBasic science
Summary
The overall aim of this study is to evaluate two different central venous lines, PICC-lines (PICC) and subcutaneous venous access ports (SVAP) used for chemotherapy in women with breast cancer. The study will compare complications, material wear of the catheters used, patients'- and health care professionals' experiences, and costs. The study will give knowledge about which central venous access that is the most advantageous regarding adjuvant chemotherapy for women with breast cancer in the aspects of safety, quality of care, and quality of life.
Timeline
- Start
- 2016-04-01
- Primary completion
- 2021-02-01
- Completion
- 2021-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Docetaxel | Small molecule | — | — |
| Background | Paclitaxel | Small molecule | — | — |
Indications
No indication recorded.